CRO's

“CROs have emerged as the dominant player in the field of drug testing. They have extended their reach to trial sites around the world — besting academia and, sometimes, the in-house trial groups of big pharma — on cost, and seem to have a knack for developing insights into which products are likely to hit critical endpoints required for U.S. Food and Drug Administration approval.”

 

-John Carroll, Biotechnol Health. 2005.